Xcellerex
Marlborough · Founded 2002
About Xcellerex
Xcellerex is a supplier of manufacturing technologies, developing and producing biomanufacturing systems and production-scale bioreactors. The biomanufacturing solutions transform the speed and economics of producing therapeutic proteins, including biosimilars and vaccines. Its proprietary products offer significant advantages such as faster installation, lower capital investment, reduced risk of cross-contamination, and significantly increased flexibility compared with traditional manufacturing technologies. The company’s FlexFactory® is a completely modular and portable production train based on single-use technologies, advanced process automation, and compact cleanroom architecture. In 2002, the company was founded by Parrish M. Galliher inMarlborough, Massachusetts.
Company Facts
- Founded: 2002
- Legal name: Xcellerex, Inc.
- Operating status: Acquired
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $50.5M
- Funding stage: M&A
- Last round: Debt Financing (Jan 2011)
- Website: xcellerex.com
Social Profiles
Canonical: https://fsome.com/organization/xcellerex-8296537 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.